You can buy or sell AGTC and other stocks, options, ETFs, and crypto commission-free!
Applied Genetic Technologies Corporation Common Stock, also called Applied Genetic Technologies, is a clinical stage biotechnology company, which engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. Read More The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. The listed name for AGTC is Applied Genetic Technologies Corporation Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 10, After Hours